BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2433204)

  • 41. Fraternal hepatocellular carcinoma in young children in two families.
    Chang MH; Hsu HC; Lee CY; Chen DS; Lee CH; Lin KS
    Cancer; 1984 Apr; 53(8):1807-10. PubMed ID: 6321015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
    Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ
    J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The occurrence and significance of the presence of alpha fetoprotein (AFP) and Australia antigen (HBsAg) in the serum of 392 patients with chronic disease and primary malignant neoplasms of the liver].
    Stajić M; Milosavljević J
    Acta Med Iugosl; 1978; 32(3):243-51. PubMed ID: 80098
    [No Abstract]   [Full Text] [Related]  

  • 44. Primary hepatocellular carcinoma and hepatitis B virus.
    Zuckerman AJ
    Trans R Soc Trop Med Hyg; 1982; 76(6):711-8. PubMed ID: 6298981
    [No Abstract]   [Full Text] [Related]  

  • 45. Hepatitis B surface antigen and alpha-fetoprotein in patients with hepatocellular carcinoma.
    Chen DS; Sung FL
    Gastroenterology; 1978 Jan; 74(1):163-4. PubMed ID: 72701
    [No Abstract]   [Full Text] [Related]  

  • 46. Serum alpha fetoprotein in 714 mentally retarded carriers of hepatitis B surface antigen.
    Lohiya G; Lohiya S; Fischer T; Nguyen H; Vuu T; Humerez R
    Eur J Epidemiol; 1988 Jun; 4(2):181-4. PubMed ID: 2456944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary liver cell carcinoma in the presence or absence of hepatitis B antigen.
    Fisher RL; Scheuer PJ; Sherlock S
    Cancer; 1976 Aug; 38(2):901-5. PubMed ID: 184915
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Forecasting the development of primary hepatocellular carcinoma by the use of risk factors: studies in West Africa.
    Larouzé B; Blumberg BS; London WT; Lustbader ED; Sankalé M; Payet M
    J Natl Cancer Inst; 1977 Jun; 58(6):1557-61. PubMed ID: 68119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunohistochemical studies on the association between hepatitis B surface antigen and primary hepatocellular carcinoma (author's transl)].
    Volc-Platzer B; Hanak H; Weiss W; Denk H
    Wien Klin Wochenschr; 1982 Feb; 94(4):108-14. PubMed ID: 6281995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nationwide vaccination: a success story in Taiwan.
    Huang K; Lin S
    Vaccine; 2000 Feb; 18 Suppl 1():S35-8. PubMed ID: 10683542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pathological and serological investigation on early primary hepatocellular carcinoma and its liver disease background (author's transl)].
    Sun ZT; Wang NJ; Xia QJ; Wang LQ; Zhang YL
    Zhonghua Zhong Liu Za Zhi; 1979; 1(1):13-19. PubMed ID: 95340
    [No Abstract]   [Full Text] [Related]  

  • 52. Hepatitis-B surface antigen and hepatocellular carcinoma in Taiwan. With special reference to types and localization of HBsAg in the tumor cells.
    Hsu HC; Lin WS; Tsai MJ
    Cancer; 1983 Nov; 52(10):1825-32. PubMed ID: 6313175
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Morbidity and mortality from chronic hepatitis B virus infection in family members of patients with malignant and nonmalignant hepatitis B virus-related chronic liver diseases.
    Lok AS; Lai CL; Chung HT; Lau JY; Leung EK; Wong LS
    Hepatology; 1991 May; 13(5):834-7. PubMed ID: 1709410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Immunologic and immuno-histochemical determination of alpha l-fetoprotein and HBs antigens in hepatocellular carcinoma].
    Perisić-Savić M; Perisić V; Sinćić M; Janev A; Nastić-Mirić D
    Srp Arh Celok Lek; 1981; 109(5-6):775-82. PubMed ID: 6179170
    [No Abstract]   [Full Text] [Related]  

  • 55. Hepatoma in an HBsAg carrier--seven years after perinatal infection.
    Beasley RP; Shiao IS; Wu TC; Hwang LY
    J Pediatr; 1982 Jul; 101(1):83-4. PubMed ID: 6283055
    [No Abstract]   [Full Text] [Related]  

  • 56. [Long-term course in asymptomatic carriers of HBsAg in an area of low prevalence of hepatocarcinoma].
    Jmelnitzky A; Basualdo JA; Castelletto R; Mon JC; Belloni P; Rondina A; García C
    Acta Gastroenterol Latinoam; 1989; 19(1):21-30. PubMed ID: 2481374
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clearance of hepatitis B surface antigen (HBsAg) after surgical resection of hepatocellular carcinoma.
    Wu TT; Hsu HC; Chen DS; Sheu JC; Su IJ; Chen SL; Chuang SM
    J Hepatol; 1987 Feb; 4(1):45-51. PubMed ID: 3033059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors determining the development of hepatocellular carcinoma in hepatitis B surface antigen carriers. A comparison between families with clusters and solitary cases.
    Lok AS; Lai CL
    Cancer; 1988 Apr; 61(7):1287-91. PubMed ID: 2830957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Primary hepatocellular carcinoma. Relation between serum and liver alpha fetoprotein, B virus infection, histology].
    Maggi G; Bighellini K; Borghi L
    Minerva Dietol Gastroenterol; 1985; 31(4):627-33. PubMed ID: 2418386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.